Infantile aphakic glaucoma: A proposed etiologic role of IL-4 and VEGF

Journal of Pediatric Ophthalmology and Strabismus

Volumn 48, Issue 2, 2011, Pages 98-107

  Michael, Inbal ^a   Walton, David S ^b   Levenberg, Shulamit ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE ANTIBODY; INTERLEUKIN 4; TRANSFORMING GROWTH FACTOR BETA2; VASCULOTROPIN;

APHAKIA; ARTICLE; CELL CULTURE; CELL STRUCTURE; CONGENITAL CATARACT; CONTROLLED STUDY; DISEASE COURSE; GENE EXPRESSION; GLAUCOMA; HUMAN; HUMAN CELL; LENS EPITHELIUM; MORPHOLOGY; TRABECULAR MESHWORK;

ADOLESCENT; ANTIBODIES, BLOCKING; APHAKIA; CELLS, CULTURED; COCULTURE TECHNIQUES; EPITHELIAL CELLS; GENE EXPRESSION REGULATION; GLAUCOMA, OPEN-ANGLE; HUMANS; INTERLEUKIN-4; LENS, CRYSTALLINE; TRABECULAR MESHWORK; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 79953706601     PISSN: 01913913     EISSN: None     Source Type: Journal    
DOI: 10.3928/01913913-20100518-04     Document Type: Article

References (32)

1. Chen TC, Bhatia LS, Halpern EF, Walton DS. Risk factors for the development of aphakic glaucoma after congenital cataract surgery. J Pediatr Ophthalmol Strabismus. 2006;43:274-280.
2. Chen TC, Walton DS, Bhatia LS. Aphakic glaucoma after congenital cataract surgery. Arch Ophthalmol. 2004;122:1819-1825.
3. Haargaard B, Ritz C, Oudin A, et al. Risk of glaucoma after pediatric cataract surgery. Invest Ophthalmol Vis Sci. 2008;49:1791-1796.
4. Michael I, Shmoish M, Walton DS, Levenberg S. Interactions between trabecular meshwork cells and lens epithelial cells: a possible mechanism in infantile aphakic glaucoma. Invest Ophthalmol Vis Sci. 2008;49:3981-3987.
5. Davidson MG, Harned J, Grimes AM, Duncan G, Wormstone IM, McGahan MC. Transferrin in after-cataract and as a survival factor for lens epithelium. Exp Eye Res. 1998;66:207-215.
6. Davidson MG, Wormstone M, Morgan D, Malakof R, Allen J, McGahan MC. Ex vivo canine lens capsular sac explants. Graefes Arch Clin Exp Ophthalmol. 2000;238:708-714.
7. Meacock WR, Spalton DJ, Stanford MR. Role of cytokines in the pathogenesis of posterior capsule opacification. Br J Ophthalmol. 2000;84:332-336.
8. Shigemitsu T, Ishiguro K, Shimizu Y, Horiguchi M, Kasahara M, Arakaki S. Immunocytochemical features of lens after cataract tissue- signalling molecules (growth factors, cytokines, other signalling molecules), cytoskeleton proteins, cellular and extracellular matrix proteins. Int Ophthalmol. 1999;23:137-144.
9. Wallentin N, Wickstrom K, Lundberg C. Effect of cataract surgery on aqueous TGF-beta and lens epithelial cell proliferation. Invest Ophthalmol Vis Sci. 1998;39:1410-1418.
10. Yao K, Tan J, Ye P, et al. Integrin beta1-mediated signaling is involved in transforming growth factor-beta2-promoted migration in human lens epithelial cells. Mol Vis. 2007;13:1769-1776.
11. Wormstone IM, Tamiya S, Eldred JA, et al. Characterisation of TGF-beta2 signalling and function in a human lens cell line. Exp Eye Res. 2004;78:705-714.
12. Liu T, Liu Y, Wu M. Pigment epithelium-derived factor in cataractous aqueous humor and lens epithelial cells. Eye Science. 2006;22:40-46, 53.
13. Allen JB, Davidson MG, Nasisse MP, Fleisher LN, McGahan MC. The lens influences aqueous humor levels of transforming growth factor-beta 2. Graefes Arch Clin Exp Ophthalmol. 1998;236:305-311.
14. Tu KL, Kaye SB, Sidaras G, Taylor W, Shenkin A. Effect of intraocular surgery and ketamine on aqueous and serum cytokines. Mol Vis. 2007;13:1130-1137.
15. Nishi O, Nishi K, Fujiwara T, Shirasawa E, Ohmoto Y. Effects of the cytokines on the proliferation of and collagen synthesis by human cataract lens epithelial cells. Br J Ophthalmol. 1996;80:63-68.
16. Nishi O, Nishi K, Ohmoto Y. Synthesis of interleukin-1, interleukin-6, and basic fibroblast growth factor by human cataract lens epithelial cells. J Cataract Refract Surg. 1996;22(suppl 1):852-858.
17. Wormstone IM, Del Rio-Tsonis K, McMahon G, et al. FGF: an autocrine regulator of human lens cell growth independent of added stimuli. Invest Ophthalmol Vis Sci. 2001;42:1305-1311.
18. Singh DP, Ohguro N, Kikuchi T, et al. Lens epithelium-derived growth factor: effects on growth and survival of lens epithelial cells, keratinocytes, and fibroblasts. Biochem Biophys Res Commun. 2000;267:373-381.
19. Tholozan FM, Gribbon C, Li Z, et al. FGF-2 release from the lens capsule by MMP-2 maintains lens epithelial cell viability. Mol Biol Cell. 2007;18:4222-4231.
20. Ishizaki Y, Voyvodic JT, Burne JF, Raff MC. Control of lens epithelial cell survival. J Cell Biol. 1993;121:899-908.
21. Futter CE, Crowston JG, Allan BD. Interaction with collagen IV protects lens epithelial cells from Fas-dependent apoptosis by stimulating the production of soluble survival factors. Invest Ophthalmol Vis Sci. 2005;46:3256-3262.
22. Allen JB, Davidson MG, Nasisse MP, Fleisher LN, McGahan MC. The lens influences aqueous humor levels of transforming growth factor-beta 2. Graefes Arch Clin Exp Ophthalmol. 1998;236:305-311.
23. Zhao X, Ramsay KE, Stephan DA, Russell P. Gene and protein expression changes in human trabecular meshwork cells treated with transforming growth factor-beta. Invest Ophthalmol Vis Sci. 2004;45:4023-4034.
24. Wordinger RJ, Clark AF, Agarwal R, et al. Cultured human trabecular meshwork cells express functional growth factor receptors. Invest Ophthalmol Vis Sci. 1998;39:1575-1589.
25. Guay J, Lambert H, Gingras-Breton G, Lavoie JN, Huot J, Landry J. Regulation of actin filament dynamics by p38 map kinase-mediated phosphorylation of heat shock protein 27. J Cell Sci. 1997;110:357-368.
26. Blondin C, Hamard P, Brignole F, Baudouin C. Human trabecular meshwork cells produce the pro-inflammatory chemokines Interleukin-8 (IL-8) and Monocyte Chemoattractant Protein-1 (MPC-1) in vitro. Invest Ophthalmol Vis Sci. 2003;44-ARVO E-Abstract 679.
27. Blondin C, Pauly A, Hamard P, Baudouin C. IL-4 and TGFb2 modulate TNF-alpha- and IL-1beta-induced IL-8 and MCP-1 production by human glaucomatous trabecular meshwork cells. Invest Ophthalmol Vis Sci. 2004;45-ARVO E-Abstract 902.
28. Liton PB, Luna CL, Challa P, Epstein DL, Gonzalez P. Genome-wide expression profile of human trabecular meshwork cultured cells, nonglaucomatous and primary open angle glaucoma tissue. Mol Vis. 2006;12:774-790.
29. Shui YB, Wang X, Hu JS, et al. Vascular endothelial growth factor expression and signaling in the lens. Invest Ophthalmol Vis Sci. 2003;44:3911-3919.
30. Ferrara N, Mass RD, Campa C, Kim R. Targeting VEGF-A to treat cancer and age-related macular degeneration. Annu Rev Med. 2007;58:491-504.
31. Tripathi RC, Li J, Tripathi BJ, Chalam KV, Adamis AP. Increased level of vascular endothelial growth factor in aqueous humor of patients with neovascular glaucoma. Ophthalmology. 1998;105:232-237.
32. Lip PL, Felmeden DC, Blann AD, et al. Plasma vascular endothelial growth factor, soluble VEGF receptor FLT-1, and von Willebrand factor in glaucoma. Br J Ophthalmol. 2002;86:1299-1302.